Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Aug 11, 2014 at 9:11 AM EDT

MannKind Secures Future of Afrezza in Major Sanofi Deal

ThinkstockMannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of…

Jon C. Ogg | Aug 7, 2014 at 11:05 AM EDT

Thoratec Implodes on Guidance and Revenue Miss

Thoratec was the king of the stock drops in Wednesday's after-hours trading session. We have seen multiple analyst downgrades as…

Lee Jackson | Aug 7, 2014 at 8:20 AM EDT

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

We have seen four biotech research reports in which the analysts covering these stocks are now calling for upside of…

Lee Jackson | Aug 5, 2014 at 10:10 AM EDT

5 Affordable Care Act Stock Winners to Buy Now

A new research report from the analysts at Stifel notes that the managed care organizations (MCOs) have posted solid results…

Jon C. Ogg | Aug 4, 2014 at 11:40 AM EDT

Should Investors Really Be Chasing Potential Ebola Treatments?

ThinkstockThe world is dealing with Ebola outbreaks and scares again. We are also in the midst of debates as to…

Jon C. Ogg | Aug 1, 2014 at 10:20 AM EDT

Do Layoffs in Biotech Send the Right Message?

This week's layoff announcement by Amgen may have investors and the public starting to rethink what "being a biotech company"…

Paul Ausick | Jul 29, 2014 at 7:50 AM EDT

Drugmakers Merck, Pfizer Eke Out Profit Hikes

Drug giants Merck and Pfizer reported better-than-expected second-quarter 2014 results before markets opened Tuesday morning.

Paul Ausick | Jul 25, 2014 at 8:40 AM EDT

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira…

Jon C. Ogg | Jul 23, 2014 at 4:41 PM EDT

You Just Won’t Believe Gilead’s Profit Margins

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings…

Jon C. Ogg | Jul 23, 2014 at 11:45 AM EDT

Is Puma Biotech For Real, Again?

Puma Biotechnology has just defied all odds in biotech. The stock has risen more than 200% in a single day,…

Paul Ausick | Jul 21, 2014 at 9:45 AM EDT

Allergan Chops 1,500 Jobs to Fend Off Valeant

Allergan reported better-than-expected second-quarter 2014 results before markets opened Monday morning. The Botox-maker also announced that it will execute a…

Paul Ausick | Jul 21, 2014 at 8:30 AM EDT

Valeant Offer Weaker After Allergan Earnings

In a sharply worded press release Monday morning, Valeant Pharmaceuticals said that it "can no longer tolerate" statements from Allergan…

Lee Jackson | Jul 21, 2014 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

New research reports from the biotech, health care and medical device teams at Deutsche Bank raise price targets on three…

Jon C. Ogg | Jul 20, 2014 at 9:11 AM EDT

Top Biotech Earnings Previews for the Week Ahead

ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector…

Lee Jackson | Jul 18, 2014 at 9:15 AM EDT

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

ThinkstockFor the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street…

1 … 283 284 285 286 287 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

MannKind Secures Future of Afrezza in Major Sanofi Deal

Thoratec Implodes on Guidance and Revenue Miss

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

5 Affordable Care Act Stock Winners to Buy Now

Should Investors Really Be Chasing Potential Ebola Treatments?

Do Layoffs in Biotech Send the Right Message?

Drugmakers Merck, Pfizer Eke Out Profit Hikes

AbbVie Earnings Take Back Seat to Shire Merger

You Just Won’t Believe Gilead’s Profit Margins

Is Puma Biotech For Real, Again?

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

Top Biotech Earnings Previews for the Week Ahead

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

The Fed Could Crush Trump’s Bull Market — Here’s the Warning Wall Street Is Missing

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won’t Tell You About

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won't Tell You About

“Sitting on a Tax Time Bomb”: Jim Saulnier’s Warning to Retiree With $2 Million

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Health and Healthcare Articles

All Health and Healthcare Articles

MannKind Secures Future of Afrezza in Major Sanofi Deal

Thoratec Implodes on Guidance and Revenue Miss

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

5 Affordable Care Act Stock Winners to Buy Now

Should Investors Really Be Chasing Potential Ebola Treatments?

Do Layoffs in Biotech Send the Right Message?

Drugmakers Merck, Pfizer Eke Out Profit Hikes

AbbVie Earnings Take Back Seat to Shire Merger

You Just Won’t Believe Gilead’s Profit Margins

Is Puma Biotech For Real, Again?

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

Top Biotech Earnings Previews for the Week Ahead

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

The Fed Could Crush Trump’s Bull Market — Here’s the Warning Wall Street Is Missing

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won’t Tell You About

Featured Reads

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million

The Triple-Tax-Free Account Doctors Are Maxing Before Their 401(k) and Most Plans Won't Tell You About